z-logo
open-access-imgOpen Access
Long-term outcomes of EUS-guided lauromacrogol ablation for the treatment of pancreatic cystic neoplasms: 5 years of experience
Author(s) -
Chen Du,
Ningli Chai,
Enqiang Linghu,
Huikai Li,
Xiuxue Feng,
Bo Niu,
Xiangdong Wang,
Peng Tang
Publication year - 2022
Publication title -
endoscopic ultrasound
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.883
H-Index - 24
eISSN - 2303-9027
pISSN - 2226-7190
DOI - 10.4103/eus-d-20-00231
Subject(s) - medicine , ablation , adverse effect , pancreas , population , surgery , radiology , environmental health
We initially reported EUS-guided lauromacrogol ablation (EUS-LA) to treat pancreatic cystic neoplasms (PCNs); however, its long-term effectiveness remains unknown. This study was performed to further determine the effectiveness of EUS-LA in a larger population with a long-term follow-up based on 5 years of experience with EUS-LA.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here